Drawing for SALES THERAPY

USPTO serial 99556424

SALES THERAPY

Reviewed by CopyMark Law Group

Status 774
Filing date
Status date
Registration date
Examiner
REYNOLDS,DYLAN M

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SALES THERAPY?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

Owner

  • Kendra Simmons

    Lanham, MD, US

  • Kendra Simmons

    Lanham, MD, US

Goods and services

ClassDescriptionStatusFirst use
041Business education and training services, namely, developing customized leadership and executive development programs, providing executive coaching services, and providing business education programs to employees and executives; Business education and training services, namely, developing customized in-company leadership and executive development programs, providing executive coaching services, and providing public and in-company keynote presentations to business leadersACTIVEMay 27, 2025

Prosecution history

DateCodeEvent
Aug 10, 2026ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Aug 8, 2026OP.IOPPOSITION INSTITUTED NO. 999999
Jul 8, 2026ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
Jun 9, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 9, 2026PUBOPUBLISHED FOR OPPOSITION
Jun 3, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 14, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
May 14, 2026XAECEXAMINER'S AMENDMENT ENTERED
May 14, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 14, 2026GNEAEXAMINERS AMENDMENT E-MAILED
May 14, 2026CNEAEXAMINERS AMENDMENT -WRITTEN
May 1, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
May 1, 2026GNRTNON-FINAL ACTION E-MAILED
May 1, 2026CNRTNON-FINAL ACTION WRITTEN
Apr 22, 2026DOCKASSIGNED TO EXAMINER
Apr 10, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 18, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Dec 18, 2025NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance